There is a lack of large, openly available, and expert-labelled data sets from Electronic Health Records in this area, and models trained on MIMIC-III may not simply generalise to other data sets due to the difference in length, style, and language (for example, clinical notes in China, Spain, or even the UK)

Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
Enhance your natural glow from within with our delicious Glutathione Gummies, formulated to support a more radiant and even skin tone
Inhibition of inflammatory factors secretion and increasing barrier function are their therapeutic effects [17]
Enhances exercise performance, supports fat metabolism, improves energy production Metabolic Health, Gut Health & Weight Loss AOD 9604 A modified growth-hormone fragment designed to focus on fat metabolism